iRadimed Corp Forecast, price target & analysts
iRadimed Corp Target price 2026 - Analyst rating & recommendation
iRadimed Corp Classifications & Recommendation
iRadimed Corp Price Target
| Target Price | $120.36 |
| Price | $85.76 |
| Potential |
40.35%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target iRadimed Corp 2027 .
The average iRadimed Corp target price is $120.36.
This is
40.35%
register free of charge
$126.00
46.92%
register free of charge
$117.16
36.61%
register free of charge
|
|
| A rating was issued by 8 analysts: 7 Analysts recommend iRadimed Corp to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the iRadimed Corp stock has an average upside potential 2027 of
40.35%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 83.81 | 93.13 |
| 14.43% | 11.12% | |
| EBITDA Margin | 32.59% | 34.72% |
| 4.77% | 6.55% | |
| Net Margin | 26.82% | 29.28% |
| 2.16% | 9.16% |
4 Analysts have issued a sales forecast iRadimed Corp 2026 . The average iRadimed Corp sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an iRadimed Corp EBITDA forecast 2026. The average iRadimed Corp EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 iRadimed Corp Analysts have issued a net profit forecast 2026. The average iRadimed Corp net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 1.75 | 2.13 |
| 16.67% | 21.71% | |
| P/E | 40.23 | |
| EV/Sales | 11.14 |
4 Analysts have issued a iRadimed Corp forecast for earnings per share. The average iRadimed Corp EPS is
This results in the following potential growth metrics and future valuations:
Current iRadimed Corp Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Needham |
Locked
➜
Locked
|
Locked | Sep 22 2026 |
| Roth MKM |
Locked
➜
Locked
|
Locked | Feb 14 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Needham:
Locked
➜
Locked
|
Sep 22 2026 |
|
Locked
Roth MKM:
Locked
➜
Locked
|
Feb 14 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
